---
title: "Inventiva tumbles 8% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306315981.md"
description: "Inventiva fell 8.12% to US$3.170. Down 13.86% over five sessions and down 31.83% YTD."
datetime: "2026-11-20T18:37:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306315981.md)
  - [en](https://longbridge.com/en/news/306315981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306315981.md)
generator: "portal-rs"
---

# Inventiva tumbles 8% during regular trading

Inventiva (IVA.US) tumbled more than **8%** during regular trading to **$3.17**.

The stock is down 13.86% over the past five sessions and down 31.83% year to date. It sits 56.52% below its 52-week high of US$7.290. Volume was 3.50 times its average.

The Nasdaq Composite is down 8.15% over the past five sessions and down 0.67% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [IVA.US](https://longbridge.com/en/quote/IVA.US.md)

## Related News & Research

- [J.P. Morgan Raises Inventiva Voting Rights to 5.21%](https://longbridge.com/en/news/305310429.md)
- [IVA: NATiV3 readout could shape lanifibranor’s MASH opportunity and path to a 2028 launch](https://longbridge.com/en/news/304901164.md)
- [Space Exploration Technologies (SPCX) Gets A New Hiring Twist As Musk Eyes Top AI Talent](https://longbridge.com/en/news/306383945.md)
- [Salesforce (CRM) Chosen To Lead U.S. Backed Super Intelligence Export Group](https://longbridge.com/en/news/306383121.md)
- [CAPR: FDA issued a CRL for Deramiocel, citing insufficient evidence of effectiveness](https://longbridge.com/en/news/306366333.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**